Soluble urokinase plasminogen activator receptor (suPAR) as an early predictor of severe respiratory failure in patients with COVID-19 pneumonia

Crit Care. 2020 Apr 30;24(1):187. doi: 10.1186/s13054-020-02897-4.

¹ 1st Department of Pulmonary Medicine and Intensive Care Unit, National and Kapodistrian University of Athens, Medical School, 115 27, Athens, Greece.
² Department of Internal Medicine, University of Patras, Medical School, 265 04, Rio, Greece.
³ Clinical Research Centre, Copenhagen University Hospital, Hvidovre, Denmark.
⁴ Department of Medicine, University of Michigan, Ann Arbor, MI, 48103, USA.
⁵ Department of Medicine, Rush University Medical Center, 1717 West Congress Parkway, Chicago, IL, 60612, USA. jochen_reiser@rush.edu.
⁶ 4th Department of Internal Medicine, National and Kapodistrian University of Athens, Medical School, 124 62, Athens, Greece. egiamarel@med.uoa.gr.
⁷ 4th Department of Internal Medicine, ATTIKON University Hospital, 1 Rimini Street, 12462, Athens, Greece. egiamarel@med.uoa.gr.

No abstract available

Keywords: COVID-19; Prognosis; Respiratory failure; suPAR.

Publication types